VERVVerve Therapeutics Inc

$0.00
$0.00
(0.00%)
Today
Updated:
Reported EarningsMay 14
Mkt Cap$993.66M
Vol10.31M
News
all
press releases
Eli Lilly vs. Merck: Which Drug Giant Appears Better Poised Today?
LLY's explosive growth from Mounjaro and Zepbound outpaces MRK's Keytruda-led gains, despite valuation concerns.
Zacks
News Placeholder
More News
News Placeholder
BMO downgrades Verve Therapeutics saying Lilly buyout deal caps upside
Investing.com -- BMO Capital Markets downgraded Verve Therapeutics to Market perform, saying Eli Lilly’s agreement to buy the gene-editing specialist leaves limited room for the stock to rise before the transaction is expected to close in the third quarter of 2025.
investing.com
News Placeholder
Gene-Editing Stocks Gain on LLY-VERV Deal Announcement
Zacks
News Placeholder
Verve Therapeutics Stock Rockets 75% Pre-Market After Eli Lilly Agrees To Acquire The Company For Up To $1.3B: Retail Says Offer Is ‘Low’
Lilly will acquire all outstanding shares of Verve for $10.50 per share in cash payable at closing, in addition to a contingent value right (CVR) per share that entitles holders to $3 per share, subject to the completion of certain milestones.
Stocktwits
News Placeholder
Verve Therapeutics Soars 75% After-Hours Following Report Of $1.3B Eli Lilly Takeover Talks
The deal would double Verve’s market value and expand Lilly’s pipeline of early-stage therapies.
Stocktwits
News Placeholder
Eli Lilly close to buying gene editing firm Verve for $1.3 bln- FT
Investing.com-- Eli Lilly and Company (NYSE:LLY) is in advanced talks to buy gene editing start-up Verve Therapeutics Inc (NASDAQ:VERV), the Financial Times reported on Monday, as the world’s biggest drugmaker seeks to increase its pipeline of experimental drugs. 
investing.com
News Placeholder
What Makes Verve Therapeutics (VERV) a New Buy Stock
Zacks
News Placeholder
Verve Therapeutics (VERV) Just Reclaimed the 200-Day Moving Average
Zacks
News Placeholder
Wall Street Analysts See a 367.86% Upside in Verve Therapeutics (VERV): Can the Stock Really Move This High?
Zacks
News Placeholder
3 Top Genomics Stocks to Add to Your Portfolio in 2025
Zacks
<
1
2
...
>

Advertisement|Remove ads.